The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 trial of cetuximab for patients with locally advanced/metastatic chordoma.
 
Anthony Conley
Consulting or Advisory Role - AADi; Applied Clinical Intelligence; Bayer; Deciphera; Deciphera; Genentech; Guidepoint Global; Guidepoint Global; Guidepoint Global; InhibRx; Medscape; Nektar; Novartis; OncLive; Schlesinger Associates
Research Funding - Bavarian Nordic (Inst); Chordoma Foundation (Inst); EpicentRx (Inst); Ignyta (Inst); InhibRx (Inst); Iovance Biotherapeutics (Inst); Krystal Biotech; Lilly (Inst); MedImmune (Inst); NantHealth (Inst); NCI (Inst); SERVIER
Travel, Accommodations, Expenses - Genentech
 
J. Livingston
Consulting or Advisory Role - Ipsen
Research Funding - Exelixis (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Ipsen
Other Relationship - Guidepoint Global
 
Carlos Torrado
Stock and Other Ownership Interests - Pfizer; Summit Therapeutics
 
Vinod Ravi
Stock and Other Ownership Interests - AstraZeneca; Merck; Moderna Therapeutics; Pfizer; TRACON Pharma
Honoraria - UpToDate
Consulting or Advisory Role - AADi; Daiichi Sankyo; Daiichi Sankyo; Deciphera; Deciphera; EMD Serono; Gerson Lehrman Group; Guidepoint Inc
Research Funding - AADi (Inst); Athenex (Inst); Deciphera (Inst); Ikena Oncology (Inst); Ikena Oncology (Inst); Novartis (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate
Travel, Accommodations, Expenses - Daiichi Sankyo; EMD Serono/Merck
 
Shaan Raza
No Relationships to Disclose
 
Laurence Rhines
Honoraria - AO Spine; icotec Medical; Stryker
Consulting or Advisory Role - AO Spine; icotec Medical; Stryker
Travel, Accommodations, Expenses - AO Spine; icotec Medical; Stryker
 
Andrew Bishop
No Relationships to Disclose
 
Amol Ghia
Honoraria - IcoTec
Research Funding - BrainLAB
 
David Grosshans
No Relationships to Disclose
 
Wei-Lien Wang
No Relationships to Disclose
 
Alexander Lazar
Leadership - Archer; Iterion Therapeutics; Modella; Nucleai
Stock and Other Ownership Interests - Archer; Beta Cat Pharmaceuticals; PAIGE.AI
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Novartis
Consulting or Advisory Role - Abbvie; Bayer; BMS; Deciphera; Moderna/Merck Collaboration; Novartis
Research Funding - AstraZeneca; MedImmune; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Elsevier
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Justin Bird
No Relationships to Disclose
 
Christopher Alvarez-Breckenridge
No Relationships to Disclose
 
Bryan Moon
No Relationships to Disclose
 
Claudio Tatsui
No Relationships to Disclose
 
Gregory Cote
Honoraria - Gilead Sciences
Consulting or Advisory Role - Ikena Oncology; Parabilis; PharmaMar
Research Funding - Bavarian Nordic; BioAtla (Inst); C4 Therapeutics (Inst); Eisai (Inst); Foghorn Therapeutics (Inst); Ikena Oncology (Inst); InhibRx (Inst); Jazz Pharmaceuticals (Inst); Kronos Bio (Inst); Merck KGaA (Inst); Parabilis (Inst); PharmaMar (Inst); Pyxis (Inst); Repare Therapeutics (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Josh Sommer
Other Relationship - Chordoma Foundation
 
Daniel Freed
Consulting or Advisory Role - Incyclix Bio
 
Neeta Somaiah
Stock and Other Ownership Interests - JNJ (I); Pfizer (I)
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; Boehringer Ingelheim; Deciphera; Ipsen; Replimune
Research Funding - Advenc (Inst); Ascentage Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Cogent Biosciences (Inst); Daiichi Sankyo/Lilly (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); IDRx (Inst); Karyopharm Therapeutics (Inst)
 
Shreyaskumar Patel
Consulting or Advisory Role - Daiichi Sankyo; Deciphera; Kura Oncology; Thermosome
Research Funding - Ascendo (Inst); Kura Oncology (Inst)